Mavik and Elavil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mavik (trandolapril) and Elavil (amitriptyline hydrochloride). Common drug interactions include leukocytosis among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Mavik and Elavil. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.

What is Mavik?

Mavik has active ingredients of trandolapril. It is often used in high blood pressure. eHealthMe is studying from 3,145 Mavik users. Check the latest studies of Mavik.

What is Elavil?

Elavil has active ingredients of amitriptyline hydrochloride. It is often used in depression. eHealthMe is studying from 20,724 Elavil users. Check the latest studies of Elavil.

On Jul, 10, 2026

37 people who take Mavik and Elavil together, and have interactions are studied.

What are the common drug interactions of Mavik and Elavil, by gender? *:

female:

Leukocytosis (increased white blood cells)
Obsessive-compulsive disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;)
Pancreatitis acute (sudden inflammation of pancreas)
Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur)
Parotid gland enlargement
Pharyngolaryngeal pain
Sinusitis (inflammation of sinus)
Cough
Increased upper airway secretion
Nausea (feeling of having an urge to vomit)

male:

Asthenia (weakness)
Malaise (a feeling of general discomfort or uneasiness)
Productive cough
Asthenopia (eyestrain-tiredness of the eyes caused by prolonged close work by a person with an uncorrected vision problem)
Blood glucose increased
Diarrhoea
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Dysuria (painful or difficult urination)
Eye discharge
Eye infection

What are the common drug interactions of Mavik and Elavil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)

30-39:

n/a

40-49:

Influenza like illness
Infusion related reaction
Nephrolithiasis (calculi in the kidneys)
Weight increased
Abdominal distension
Abdominal mass (localized enlargement or swelling in the human abdomen)
Alanine aminotransferase increased
Blood alkaline phosphatase nos increased

50-59:

Eye infection
Fatigue (feeling of tiredness)
Infection
Influenza
Injection site haemorrhage (bleeding from injection site)
Injection site pain
Malaise (a feeling of general discomfort or uneasiness)
Nasopharyngitis (inflammation of the nasopharynx)
Ocular hyperaemia (an abnormally large amount of blood in eye)
Oropharyngeal pain

60+:

Back pain
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cough
Drug dependence
Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
Hepatic steatosis (fatty liver disease)
Leukocytosis (increased white blood cells)
Obsessive-compulsive disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;)
Pain
Pain in extremity

What are the existing conditions these people have? *

Pain: 18 people, 48.65%
Ankylosing Spondylitis (type of arthritis affecting the spine): 15 people, 40.54%
High Blood Cholesterol: 11 people, 29.73%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 8.11%
Hepatitis C: 2 people, 5.41%
Basedow's Disease (autoimmune disease where the thyroid is overactive, producing an excessive amount of thyroid hormones): 2 people, 5.41%

* Approximation only. Some reports may have incomplete information.

Do you take Mavik and Elavil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously